These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 9379065

  • 21. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
    Kreuwel HT, Morgan DJ, Krahl T, Ko A, Sarvetnick N, Sherman LA.
    J Immunol; 1999 Oct 15; 163(8):4335-41. PubMed ID: 10510373
    [Abstract] [Full Text] [Related]

  • 22. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl M, van Lopik T, Limburg PC, Spronk PE, Jaegers SM, Aarden LA, Smeenk RJ, Kallenberg GG.
    J Autoimmun; 1998 Oct 15; 11(5):457-63. PubMed ID: 9802929
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis.
    Liphaus BL, Kiss MH, Carrasco S, Goldenstein-Schainberg C.
    Clin Dev Immunol; 2006 Oct 15; 13(2-4):283-7. PubMed ID: 17162369
    [Abstract] [Full Text] [Related]

  • 26. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
    Amoura Z, Combadiere C, Faure S, Parizot C, Miyara M, Raphaël D, Ghillani P, Debre P, Piette JC, Gorochov G.
    Arthritis Rheum; 2003 Dec 15; 48(12):3487-96. PubMed ID: 14673999
    [Abstract] [Full Text] [Related]

  • 27. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
    Elsässer-Beile U, Gierschner D, Welchner T, Wetterauer U.
    Anticancer Res; 2003 Dec 15; 23(1A):433-7. PubMed ID: 12680244
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
    Devi BS, Van Noordin S, Krausz T, Davies KA.
    J Autoimmun; 1998 Oct 15; 11(5):471-5. PubMed ID: 9802931
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis.
    Bonelli M, von Dalwigk K, Savitskaya A, Smolen JS, Scheinecker C.
    Ann Rheum Dis; 2008 May 15; 67(5):664-71. PubMed ID: 17728327
    [Abstract] [Full Text] [Related]

  • 33. Spontaneous and induced apoptosis in systemic lupus erythematosus: multiple assays fail to reveal consistent abnormalities.
    Caricchio R, Cohen PL.
    Cell Immunol; 1999 Nov 25; 198(1):54-60. PubMed ID: 10612651
    [Abstract] [Full Text] [Related]

  • 34. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand.
    Georgescu L, Vakkalanka RK, Elkon KB, Crow MK.
    J Clin Invest; 1997 Nov 15; 100(10):2622-33. PubMed ID: 9366578
    [Abstract] [Full Text] [Related]

  • 35. T cell-antigen-presenting cell interactions in human systemic lupus erythematosus. Evidence for heterogeneous expression of multiple defects.
    Via CS, Tsokos GC, Bermas B, Clerici M, Shearer GM.
    J Immunol; 1993 Oct 01; 151(7):3914-22. PubMed ID: 8376810
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Aberrant expression of Fas ligand on anti-DNA autoantibody secreting B lymphocytes in patients with systemic lupus erythematosus: "immune privilege"-like state of the autoreactive B cells.
    Nagafuchi H, Wakisaka S, Takeba Y, Takeno M, Sakane T, Suzuki N.
    Clin Exp Rheumatol; 2002 Oct 01; 20(5):625-31. PubMed ID: 12412192
    [Abstract] [Full Text] [Related]

  • 38. Null cell immunoregulation in SLE.
    Stephens HA, Fitzharris P, Knight RA, Snaith ML.
    J Clin Lab Immunol; 1985 Oct 01; 18(2):55-61. PubMed ID: 2934551
    [Abstract] [Full Text] [Related]

  • 39. Increased expression of functional Fas-ligand in activated T cells from patients with systemic lupus erythematosus.
    Kovacs B, Liossis SN, Dennis GJ, Tsokos GC.
    Autoimmunity; 1997 Oct 01; 25(4):213-21. PubMed ID: 9344329
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.